- Home
- JOB vs IGC Comparison
JOB vs IGC Comparison
Compare JOB & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JOB | IGC |
|---|---|---|
| Founded | 1893 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5M | 33.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JOB | IGC |
|---|---|---|
| Price | $0.19 | $0.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 210.2K | ★ 496.5K |
| Earning Date | 12-23-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $108,752,000.00 | $1,106,000.00 |
| Revenue This Year | $43.94 | $3.54 |
| Revenue Next Year | N/A | $15.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.17 | $0.25 |
| 52 Week High | $0.51 | $0.50 |
Technical Indicators
Market Signals| Indicator | JOB | IGC |
|---|---|---|
| Relative Strength Index (RSI) | 43.51 | 54.57 |
| Support Level | $0.19 | $0.28 |
| Resistance Level | $0.19 | $0.36 |
| Average True Range (ATR) | 0.01 | 0.02 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 75.00 | 86.10 |
Price Performance
Historical ComparisonAbout JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.